Immutep IMMP
NASDAQ IMMP
$3.10 -0.16 (-4.70%)
As of: Oct 22, 2026 · 10:40 AM EDT

Immutep (IMMP) EBITDA Margin (2014 - 2017)

Updated

Immutep (IMMP) recorded EBITDA Margin of -528.27% in the year ended Jun 30, 2026, up 43.60 percentage points from -571.87% a year earlier.

Analysis

Immutep (IMMP) EBITDA Margin (2014 - 2017) Analysis & Trends

Starting with the year ended Jun 30, 2010, Immutep's EBITDA Margin history includes 13 years.

  • Annual EBITDA Margin has a four-year change of +18432.47 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 is the highest annual EBITDA Margin since the year ended Jun 30, 2020.
  • Per Business Quant data, IMMP's EBITDA Margin was -571.87% in the year ended Jun 30, 2025 and -18960.74% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,175.94 Bn 1,144.53 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 638.47 Bn 556.99 Bn 17.26 Bn 35.95%
3 AbbVie 504.39 Bn 477.51 Bn 12.70 Bn 49.01%
4 Merck 377.60 Bn 331.98 Bn 12.21 Bn 6.02%
5 Novartis Ag 304.31 Bn 268.30 Bn 11.24 Bn -
6 Astrazeneca 267.64 Bn 241.32 Bn 12.86 Bn 33.11%
7 Amgen 242.06 Bn 197.45 Bn 7.24 Bn 46.01%
8 Gilead Sciences 193.83 Bn 168.03 Bn 6.22 Bn -124.26%
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn 39.16%
10 Immutep 22.57 Mn -188.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 183.87%
Mar 31, 2017 -160.92%
Jun 30, 2016 3,421,600.76%
Mar 31, 2016 -894.17%
Jun 30, 2015 -18,838.90%
Jun 30, 2014 -80,677.40%
API Access

Immutep EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY